Profile
Yan Xia is currently a Member of the Supervisory Board at Heidelberg Pharma AG.
Former positions include Director of the ADC Research Center at Huadong Medicine Co., Ltd. and Analyst at Quadria Capital Investment Management Pte Ltd. Education includes a doctorate from Vanderbilt University and an undergraduate degree from Nanyang Technological University.
Yan Xia active positions
| Companies | Position | Start |
|---|---|---|
| HEIDELBERG PHARMA AG | Director/Board Member | - |
Former positions of Yan Xia
| Companies | Position | End |
|---|---|---|
| HUADONG MEDICINE CO., LTD | Corporate Officer/Principal | - |
Quadria Capital Investment Management Pte Ltd.
Quadria Capital Investment Management Pte Ltd. Investment ManagersFinance Quadria Capital invests in companies located in Singapore, primarily in South and Southeast Asia. The firm targets companies operating in the fields of life sciences, medical technology and healthcare sectors and industries. It provides financing for growth stage capital requirements. | Private Equity Analyst | - |
Training of Yan Xia
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Vanderbilt University
Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Heidelberg Pharma AG
Heidelberg Pharma AG Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Health Technology |
Huadong Medicine Co., Ltd.
Huadong Medicine Co., Ltd. Pharmaceuticals: MajorHealth Technology Produces traditional Chinese medicines and herbs | Health Technology |
Nanyang Technological University
Nanyang Technological University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quadria Capital Investment Management Pte Ltd.
Quadria Capital Investment Management Pte Ltd. Investment ManagersFinance Quadria Capital invests in companies located in Singapore, primarily in South and Southeast Asia. The firm targets companies operating in the fields of life sciences, medical technology and healthcare sectors and industries. It provides financing for growth stage capital requirements. | Finance |
- Stock Market
- Insiders
- Yan Xia
















